Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks on Jim Cramer’s radar recently. When a caller asked about the stock during the lightning round, Cramer stated: “I don’t know. It’s ...

Recursion Pharmaceuticals, a Salt Lake City-based biotechnology company using machine learning artificial intelligence to develop new drugs, raised $121 million in its latest funding round.

Development of more sophisticated ideas in data type and structure, with an introduction to the connection between data structures and the algorithms they support. Data abstraction. Controlled access ...

In early May, Salt Lake City-based Recursion Pharmaceuticals announced that it was releasing an open-source, 300-gigabyte dataset of genetically altered cell images to accelerate the use of artificial ...